logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

Changli International (01693.HK) shareholders transferred their stock from Hong Kong Shanghai HSBC to Yalituo Securities, with a transfer value of 47.3821 million Hong Kong dollars.

date
25/07/2025
According to the latest information from the WiseMoney App, Hong Kong Exchanges and Clearing Limited (HKEX) showed that on July 23, shareholders of Changli International (01693.HK) transferred their shares from HSBC Bank (Hong Kong) to Yalituo Securities, with a transfer market value of HK$47.3821 million, accounting for 45.51%.
Latest
2 m ago
Shenghualand Holdings Limited (08106.HK) controlling shareholder plans to change hands and will receive approximately 20.20% of the full acquisition offer from Shanghai Xinhua and Cloud Odd. The resumption of trading will take place on July 28th.
5 m ago
U.S. stock market anomaly | Linkhome (LHAI.US), a newly listed stock, once rose nearly 130% and triggered another trading halt.
5 m ago
Medical research and drug development company Sarepta Therapeutics Inc. fell by more than 13.66% at one point, leading to a cumulative decline of over 20.96% in the past five trading days. An advisory committee of the European Medicines Agency has recommended against approving the company's gene therapy Elevidys.
6 m ago
The Ministry of Industry and Information Technology will accelerate the construction of the open source system.
7 m ago
Trump hints that the Federal Reserve may cut interest rates.
See all latestmore
logo
Contact US
qr
+852 - 60190728
[email protected]
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2025 GMT EIGHT Holdings. All Rights Reserved.